As far as we know, few studies have evaluated the feasibility of utilizing an ultrasound radiomics method in breast carcinoma to predict the luminal BC, and currently most of these focus on predicting triple-negative breast carcinoma, HER2 status, Ki-67 index, etc. This evidence concerns the gene ERBB2 and breast cancer.